Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis.
Authors
Yuan H, Natekar A, Park J, Lauritsen CG, Viscusi ER, Marmura MJ
Abstract
Subanesthetic ketamine infusion has been used for managing refractory headache in inpatient or outpatient infusion settings. Intranasal ketamine may be an alternative option for outpatient care.
